However, data in breast cancer patients are less clear, with TXA2S expressed at significantly lower levels in patients with high grade tumors with poor prognostic outcome [68] in one study but high TBXAS1 expression correlated with invasive disease and higher tumor grades in another [69]. This evidence concerns the gene TBXAS1 and breast carcinoma.